A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis

Clinical Immunology

Volumn 136, Issue 2, 2010, Pages 236-244

  Shao, Wen Hai ^a   Zhen, Yuxuan ^a   Rosenbaum, Joshua ^b   Eisenberg, Robert A ^b   McGaha, Tracy L ^c   Birkenbach, Mark ^a   Cohen, Philip L ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Apoptotic clearance; Cytokine regulation; Glomerulonephritis; MerTK

Indexed keywords

PROTEIN MER; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GLOMERULUS EPITHELIUM; IMMUNOREGULATION; MOUSE; NECROSIS; NEPHRITIS; NEPHROTOXICITY; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; SURVIVAL RATE;

ANIMALS; APOPTOSIS; CHEMOKINE CCL2; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNE SERA; KIDNEY GLOMERULUS; MICE; MICE, KNOCKOUT; NEPHRITIS; NEUTROPHILS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SHEEP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954309871     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.04.002     Document Type: Article

References (35)

1. Du Y., Fu Y., Mohan C. Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis. Arch. Immunol. Ther. Exp. (Warsz) 2008, 56:31-40.
2. Watson S., Cailhier J.F., Hughes J., Savill J. Apoptosis and glomerulonephritis. Curr. Dir. Autoimmun. 2006, 9:188-204.
3. Couser W.G. Mechanisms of glomerular injury: an overview. Semin. Nephrol. 1991, 11:254-258.
4. Couser W.G. Mediation of immune glomerular injury. J. Am. Soc. Nephrol. 1990, 1:13-29.
5. Wang Y., Rangan G.K., Goodwin B., Tay Y.C., Harris D.C. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int. 2000, 57:2011-2022.
6. Pawluczyk I.Z., Harris K.P. Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. J. Am. Soc. Nephrol. 1997, 8:1525-1536.
7. Ryffel B., Eugster H., Haas C., Le Hir M. Failure to induce anti-glomerular basement membrane glomerulonephritis in TNF alpha/beta deficient mice. Int. J. Exp. Pathol. 1998, 79:453-460.
8. Lemke G., Rothlin C.V. Immunobiology of the TAM receptors. Nat. Rev. Immunol. 2008, 8:327-336.
9. Linger R.M., Keating A.K., Earp H.S., Graham D.K. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv. Cancer Res. 2008, 100:35-83.
10. Stitt T.N., Conn G., Gore M., Lai C., Bruno J., Radziejewski C., Mattsson K., Fisher J., Gies D.R., Jones P.F., et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995, 80:661-670.
11. Liao D., Wang X., Li M., Lin P.H., Yao Q., Chen C. Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood 2008.
12. Burstyn-Cohen T., Heeb M.J., Lemke G. Lack of Protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J. Clin. Investig. 2009.
13. Yanagita M., Arai H., Ishii K., Nakano T., Ohashi K., Mizuno K., Varnum B., Fukatsu A., Doi T., Kita T. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am. J. Pathol. 2001, 158:1423-1432.
14. Yanagita M., Ishimoto Y., Arai H., Nagai K., Ito T., Nakano T., Salant D.J., Fukatsu A., Doi T., Kita T. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Investig. 2002, 110:239-246.
15. Fiebeler A., Park J.K., Muller D.N., Lindschau C., Mengel M., Merkel S., Banas B., Luft F.C., Haller H. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am. J. Kidney Dis. 2004, 43:286-295.
16. Camenisch T.D., Koller B.H., Earp H.S., Matsushima G.K. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 1999, 162:3498-3503.
17. Cohen P.L., Caricchio R., Abraham V., Camenisch T.D., Jennette J.C., Roubey R.A., Earp H.S., Matsushima G., Reap E.A. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 2002, 196:135-140.
18. Yi Z., Li L., Matsushima G.K., Earp H.S., Wang B., Tisch R. A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells. Blood 2009, 114:3191-3198.
19. Graham D.K., Bowman G.W., Dawson T.L., Stanford W.L., Earp H.S., Snodgrass H.R. Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. Oncogene 1995, 10:2349-2359.
20. Kaneko Y., Nimmerjahn F., Madaio M.P., Ravetch J.V. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 2006, 203:789-797.
21. Behrens E.M., Gadue P., Gong S.Y., Garrett S., Stein P.L., Cohen P.L. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur. J. Immunol. 2003, 33:2160-2167.
22. Kim J.H., Ha I.S., Hwang C.I., Lee Y.J., Kim J., Yang S.H., Kim Y.S., Cao Y.A., Choi S., Park W.Y. Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease. Kidney Int. 2004, 66:1826-1837.
23. Shao W.H., Zhen Y., Eisenberg R.A., Cohen P.L. The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin. Immunol. 2009.
24. Godowski P.J., Mark M.R., Chen J., Sadick M.D., Raab H., Hammonds R.G. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995, 82:355-358.
25. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211.
26. D'Cruz P.M., Yasumura D., Weir J., Matthes M.T., Abderrahim H., LaVail M.M., Vollrath D. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum. Mol. Genet. 2000, 9:645-651.
27. Smolen J.S., Steiner G., Aringer M. Anti-cytokine therapy in systemic lupus erythematosus. Lupus 2005, 14:189-191.
28. Aringer M., Smolen J.S. Cytokine expression in lupus kidneys. Lupus 2005, 14:13-18.
29. Pai R., Ha H., Kirschenbaum M.A., Kamanna V.S. Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J. Am. Soc. Nephrol. 1996, 7:914-923.
30. Shimizu S., Nakashima H., Masutani K., Inoue Y., Miyake K., Akahoshi M., Tanaka Y., Egashira K., Hirakata H., Otsuka T., Harada M. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. Rheumatology (Oxford) 2004, 43:1121-1128.
31. Viedt C., Vogel J., Athanasiou T., Shen W., Orth S.R., Kubler W., Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler. Thromb. Vasc. Biol. 2002, 22:914-920.
32. Viedt C., Orth S.R. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?. Nephrol. Dial. Transplant. 2002, 17:2043-2047.
33. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Strieter R.M., Kunkel S.L. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 1999, 163:6148-6154.
34. Li Y., Gerbod-Giannone M.C., Seitz H., Cui D., Thorp E., Tall A.R., Matsushima G.K., Tabas I. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J. Biol. Chem. 2006, 281:6707-6717.
35. Shao W.H., Eisenberg R.A., Cohen P.L. The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J. Immunol. 2008, 180:7728-7735.